---
figid: PMC9520296__fnagi-14-996646-g002
figtitle: Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
organisms:
- Mus musculus
- Rattus norvegicus
- Salmonella enterica subsp. enterica serovar Typhimurium
- Bacillus anthracis
- Homo sapiens
- Alpinia oxyphylla
pmcid: PMC9520296
filename: fnagi-14-996646-g002.jpg
figlink: /pmc/articles/PMC9520296/figure/F2/
number: F2
caption: Relationship between NLRP3-dependent pyroptosis and Alzheimer’s disease.
  Aβ deposition and Tau hyperphosphorylation are the main pathological features of
  AD, and Aβ and Tau in turn can induce neuronal pyroptosis and neuroinflammation,
  thus promoting AD progression. Aβ promotes pyroptosis by activating the NLRP3-caspase-1-GSDMD
  axis. Besides Aβ promotes K + efflux, which triggers NLRP3 inflammasome activation
  and subsequent pyroptosis. ASC can bind to Aβ to form ASC-Aβ, which promotes pyroptosis
  by activating NLRP3 inflammasome. Tau and Aβ inhibit immunophagocytosis of M2 microglia,
  promote M1 microglia polarization, and induce sustained neuroinflammation. Palonosetron
  and Methyllycaconitine inhibit 5-HT3R and α7-nAChR, respectively, which promotes
  microglia M2 polarization while inhibiting NLRP3 inflammasome expression. NF-κB
  activates and promotes miR-146a-5p transcription, which inhibits TIGAR expression,
  ultimately leading to ROS occurrence and promoting NLRP3 activation. DJ-1 promotes
  nuclear translocation of NRF2 and inhibits ROS production, thereby suppressing NLRP3
  activation. FSK, STZ promote NLRP3 inflammasome expression. MCC950, SH, L7, U50488H,
  SCH inhibit NLRP3 and attenuate neuronal pyroptosis. AF activates AMPK/GSK3β pathway,
  thus downregulating NLRP3 expression. LiCl, YZFDF, AcYVAD-CMK, AAV9-siRNA inhibit
  caspase-1 activation, thereby inhibiting neuronal pyroptosis. Mafenide derivatives,
  miRNA-22 inhibit GSDMD, thereby inhibiting neuronal pyroptosis. Aβ, β-amyloid; Tau,
  Tau protein; AD, Alzheimer’s disease; NLRP3, NLR family pyrin domain-containing
  3; ASC, Apoptosis-associated speck-like Protein; ASC-Aβ, Complex ASC-Aβ; NF-κB,
  Nuclear factor kappa β; TIGAR, TP53-induced glycolysis and apoptosis regulator;
  ROS, Reactive oxygen species; DJ-1, DJ-1 gene; NRF2, Nuclear factor E2-related factor
  2; FSK, Forskolin; STZ, Streptozotocin; MCC950, NLRP3 inflammasome inhibitor; SH,
  Sodium houttuyfonate; L7, N-salicyloyl tryptamine derivatives; U50488H, k-opioid
  receptor agonist; SCH, Schisandrin; AF, Amentoflavone; AMPK, AMP-activated protein
  kinase; GSK3β, Glycogen synthase kinase-3beta; liCl, Lithium chloride; YZFDF, Yi-Zhi-Fang-Dai
  formula; AcYVAD-CMK, Caspase-1 inhibitor; 5-HT3R, Serotonin 3 receptor; α7-nAChR,
  α7 nicotinic Ach receptor.
papertitle: Pyroptosis as a candidate therapeutic target for Alzheimer’s disease.
reftext: Yuehua Huang, et al. Front Aging Neurosci. 2022;14:996646.
year: '2022'
doi: 10.3389/fnagi.2022.996646
journal_title: Frontiers in Aging Neuroscience
journal_nlm_ta: Front Aging Neurosci
publisher_name: Frontiers Media S.A.
keywords: Alzheimer’s disease | pyroptosis | amyloid β | tau | neuroinflammation
automl_pathway: 0.9318286
figid_alias: PMC9520296__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC9520296__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9520296__fnagi-14-996646-g002.html
  '@type': Dataset
  description: Relationship between NLRP3-dependent pyroptosis and Alzheimer’s disease.
    Aβ deposition and Tau hyperphosphorylation are the main pathological features
    of AD, and Aβ and Tau in turn can induce neuronal pyroptosis and neuroinflammation,
    thus promoting AD progression. Aβ promotes pyroptosis by activating the NLRP3-caspase-1-GSDMD
    axis. Besides Aβ promotes K + efflux, which triggers NLRP3 inflammasome activation
    and subsequent pyroptosis. ASC can bind to Aβ to form ASC-Aβ, which promotes pyroptosis
    by activating NLRP3 inflammasome. Tau and Aβ inhibit immunophagocytosis of M2
    microglia, promote M1 microglia polarization, and induce sustained neuroinflammation.
    Palonosetron and Methyllycaconitine inhibit 5-HT3R and α7-nAChR, respectively,
    which promotes microglia M2 polarization while inhibiting NLRP3 inflammasome expression.
    NF-κB activates and promotes miR-146a-5p transcription, which inhibits TIGAR expression,
    ultimately leading to ROS occurrence and promoting NLRP3 activation. DJ-1 promotes
    nuclear translocation of NRF2 and inhibits ROS production, thereby suppressing
    NLRP3 activation. FSK, STZ promote NLRP3 inflammasome expression. MCC950, SH,
    L7, U50488H, SCH inhibit NLRP3 and attenuate neuronal pyroptosis. AF activates
    AMPK/GSK3β pathway, thus downregulating NLRP3 expression. LiCl, YZFDF, AcYVAD-CMK,
    AAV9-siRNA inhibit caspase-1 activation, thereby inhibiting neuronal pyroptosis.
    Mafenide derivatives, miRNA-22 inhibit GSDMD, thereby inhibiting neuronal pyroptosis.
    Aβ, β-amyloid; Tau, Tau protein; AD, Alzheimer’s disease; NLRP3, NLR family pyrin
    domain-containing 3; ASC, Apoptosis-associated speck-like Protein; ASC-Aβ, Complex
    ASC-Aβ; NF-κB, Nuclear factor kappa β; TIGAR, TP53-induced glycolysis and apoptosis
    regulator; ROS, Reactive oxygen species; DJ-1, DJ-1 gene; NRF2, Nuclear factor
    E2-related factor 2; FSK, Forskolin; STZ, Streptozotocin; MCC950, NLRP3 inflammasome
    inhibitor; SH, Sodium houttuyfonate; L7, N-salicyloyl tryptamine derivatives;
    U50488H, k-opioid receptor agonist; SCH, Schisandrin; AF, Amentoflavone; AMPK,
    AMP-activated protein kinase; GSK3β, Glycogen synthase kinase-3beta; liCl, Lithium
    chloride; YZFDF, Yi-Zhi-Fang-Dai formula; AcYVAD-CMK, Caspase-1 inhibitor; 5-HT3R,
    Serotonin 3 receptor; α7-nAChR, α7 nicotinic Ach receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APP
  - SUCLA2
  - MAPT
  - ABO
  - STS
  - PYCARD
  - IL1B
  - IL18
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - GSK3B
  - MAF
  - MAFA
  - MAFB
  - MAFF
  - MAFG
  - MAFK
  - PARK7
  - GABPA
  - NFE2L2
  - NLRP3
  - GSDMD
  - NFKB1
  - TIGAR
  - NF2
  - ST3GAL4
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - App
  - H2-Ab1
  - Mapt
  - Csnk1e
  - Abo
  - Ugt2b5
  - Pycard
  - Il1b
  - Il18
  - Gsk3b
  - Maf
  - Park7
  - Nfe2l2
  - Nlrp3
  - Gsdmd
  - Nfkb1
  - Tigar
  - sch
  - Abo3
  - Prkaa2
  - Mmd
---
